To include your compound in the COVID-19 Resource Center, submit it here.

argenx, Proteostasis, Dicerna raise follow-ons

Antibody company argenx S.E. (Euronext:ARGX; NASDAQ:ARGX), respiratory company Proteostasis Therapeutics Inc. (NASDAQ:PTI) and RNA therapeutics play Dicerna Pharmaceuticals Inc. (NASDAQ:DRNA) raised a combined $311 million in follow-on offerings.

argenx raised

Read the full 295 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE